<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001635'>Heart failure</z:hpo> (HF) is a complex syndrome with cardiac, renal, neurohormonal and sympathetic <z:mp ids='MP_0008912'>nervous</z:mp> system's manifestations, the pathogenesis of which among others is connected to <z:mp ids='MP_0001845'>inflammation</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>PAF has local and systemic effects pertaining to HF progression since it causes a negative inotropic effect, it induces <z:hpo ids='HP_0011675'>arrhythmias</z:hpo>, it induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and it is involved in <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In the present review the role of PAF in HF will be thoroughly presented along with the relevant data on PAF enzymes and the potential role of PAF metabolic circuit as a novel pharmacological target </plain></SENT>
</text></document>